Muir-Torre syndrome: Diagnostic and screening guidelines

Australasian Journal of Dermatology

Volumn 47, Issue 4, 2006, Pages 266-269

  Jones, Brad ^a   Oh, Carol ^a   Mangold, Elisabeth ^b   Egan, Conleth A ^a  

^a OUR LADY OF LOURDES HOSPITAL   (Ireland)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Genodermatoses; Hereditary non polyposis colorectal cancer; Lynch syndrome; Microsatellite instability; Mismatch repair gene; Sebaceous adenoma; Sebaceous carcinoma; Sebaceous epithelioma

Indexed keywords

AGED; ARTICLE; CASE REPORT; COLON ADENOCARCINOMA; GENE; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC SCREENING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROSATELLITE INSTABILITY; MSH2 GENE; MUIR TORRE SYNDROME; SQUAMOUS CELL CARCINOMA;

AGED; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DIAGNOSIS, DIFFERENTIAL; DNA MISMATCH REPAIR; FACE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENETIC TESTING; HUMANS; MALE; PRACTICE GUIDELINES; PRACTICE GUIDELINES AS TOPIC; SEBACEOUS GLAND NEOPLASMS;

EID: 33749539150     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2006.00292.x     Document Type: Article

References (13)

1. Hampel H, Peltomaki P. Hereditary colorectal cancer: risk assessment and management. Clin. Genet. 2000; 58: 89-97.
2. Schwartz RA, Torre DP. The Muir-Torre syndrome: a 25-year retrospect. J. Am. Acad. Dermatol. 1995; 33: 90-104.
3. Cohen PR, Kohn SR, Davis DA, Kurzrock R. Muir-Torre syndrome. Dermatol. Clin. 1995; 13: 79-89.
4. Coldron J, Reid I. Muir-Torre syndrome. J. R. Coll. Surg. Edinb. 2001; 46: 178-9.
5. Kruse R, Rutten A, Schweiger N, Jakob E, Mathiak M, Propping P, Mangold E, Bisceglia M, Ruzicka T. Frequency of microsatellite instability in unselected sebaceous gland neoplasias and hyperplasias. J. Invest. Dermatol. 2003; 120: 858-64.
6. Mangold E, Pagenstecher C, Leister M, Mathiak M, Rutten A, Friedl W, Propping P, Ruzicka T, Kruse R. A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome. J. Med. Genet. 2004; 41: 567-72.
7. Ponti G, Ponz de Leon M. Muir-Torre syndrome. Lancet Oncol. 2005; 6: 980-7.
8. Gologan A, Sepulveda AR. Microsatellite instability and DNA mismatch repair deficiency testing in hereditary and sporadic gastrointestinal cancers. Clin. Lab. Med. 2005; 25: 179-96.
9. Lynch HT, Fusaro RM. The dermatologist, genetic counseling, and cancer-associated genodermatoses. J. Am. Acad. Dermatol. 2000; 42: 1081-6.
10. Srivastava A, McKinnon W, Wood ME. Risk of breast and ovarian cancer in women with strong family histories. Oncology (Williston. Park) 2001; 15: 889-902.
11. Boardman LA. Heritable colorectal cancer syndromes: recognition and preventive management. Gastroenterol. Clin. North Am. 2002; 31: 1107-31.
12. Cruz-Correa M, Giardiello FM. Diagnosis and management of hereditary colon cancer. Gastroenterol. Clin. North Am. 2002; 31: 537-49.
13. Weber T. Clinical surveillance recommendations adopted for HNPCC. Lancet 1996; 348: 465.